Background and Study Aims: Little is known about how practices in sedation and in monitoring during gastrointestinal endoscopy and the complication rates of sedation have changed over time. The aim of this nationwide survey was to assess the present practice among Swiss gastroenterologists, with a particular focus on the use of propofol, and to compare the results with similar data obtained in 1990. Patients and Methods: At the end of 2003 a questionnaire (similar to the one used in 1990) was sent to all 249 Swiss gastroenterologists. The response rate was 72.3 %. Data from 179 953 endoscopies performed during the previous 12 months were analyzed for the study. Results: In 2003 sedation was used in 78 % of esophagogastroduodenoscopies and colonoscopies (compared with 60 % in 1990), with midazolam being the most commonly used medication. The drugs were mostly administered by the endoscopy nurse, via an intravenous cannula. Oximetry monitoring was used in more than 95 % of examinations (compared with 2.5 % in 1990). The overall sedation-related morbidity was 0.18 % and the mortality rate was 0.0014 %. Of the 180 respondents, 77 (43 %) reported that they been using propofol regularly for a median time period of 23 months. The 62 respondents (34 %) who used propofol without the assistance of an anesthesiologist had performed a total of 82 620 procedures. The morbidity (defined as the need for bag-ventilation) in this group of patients was 0.19 % and no deaths were reported. Conclusions: The use of sedation in gastrointestinal endoscopy has markedly increased over the last 13 years and the use of electronic monitoring has become standard practice. A significant percentage of Swiss gastroenterologists report that they use propofol, mainly in a hospital setting.
References
1
Bell G D.
Review article: premedication and intravenous sedation for upper gastrointestinal endoscopy.
Aliment Pharmacol Ther.
1990;
4
103-122
3
Rex D K, Imperiale T F, Portish V.
Patients willing to try colonoscopy without sedation: associated clinical factors and results of a randomized controlled trial.
Gastrointest Endosc.
1999;
49
554-559
4
Abraham N, Barkun A, Larocque M. et al .
Predicting which patients can undergo upper endoscopy comfortably without conscious sedation.
Gastrointest Endosc.
2002;
56
180-189
5
Thanvi B R, Munshi S K, Vijayakumar N. et al .
Acceptability of oesophagogastroduodenoscopy without intravenous sedation: patients' versus endoscopist's perception with special reference to older patients.
Postgrad Med J.
2003;
79
650-651
6
Heuss L T, Drewe J, Schnieper P. et al .
Patient-controlled vs. nurse-administered sedation with propofol during colonoscopy: a prospective randomized trial.
Am J Gastroenterol.
2004;
99
511-518
8
Mulcahy H E, Hennessy E, Connor P. et al .
Changing patterns of sedation use for routine outpatient diagnostic gastroscopy between 1989 and 1998.
Aliment Pharmacol Ther.
2001;
15
217-220
12
Arrowsmith J B, Gerstman B B, Fleischer D E, Benjamin S B.
Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy.
Gastrointest Endosc.
1991;
37
421-427
13
Quine M A, Bell G D, McCloy R F. et al .
Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods.
Gut.
1995;
36
462-467
14
Froehlich F, Gonvers J J, Fried M.
Conscious sedation, clinically relevant complications and monitoring of endoscopy: results of a nationwide survey in Switzerland.
Endoscopy.
1994;
26
231-234
16
Mulcahy H E, Hennessy E, Connor P. et al .
Changing patterns of sedation use for routine outpatient diagnostic gastroscopy between 1989 and 1998.
Aliment Pharmacol Ther.
2001;
15
217-220
17
Sieg A, Hachmoeller-Eisenbach U, Heisenbach T.
How safe is premedication in ambulatory endoscopy in Germany? A prospective study in gastroenterology specialty practices.
Dtsch Med Wochenschr.
2000;
125
1288-1293
22
Patterson K W, Casey P B, Murray J P. et al .
Propofol sedation for outpatient upper gastrointestinal endoscopy: comparison with midazolam.
Br J Anaesth.
1991;
67
108-111
23
Rex D K, Overley C, Kinser K. et al .
Safety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic cases.
Am J Gastroenterol.
2002;
97
1159-1163
24
Vargo J J, Zuccaro G Jr., Dumot J A. et al .
Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy: a prospective, randomized trial.
Gastroenterology.
2002;
123
8-16
25
Wehrmann T, Kokabpick S, Lembcke B. et al .
Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study.
Gastrointest Endosc.
1999;
49
677-683
27
Kulling D, Rothenbuhler R, Inauen W.
Safety of nonanesthetist sedation with propofol for outpatient colonoscopy and esophagogastroduodenoscopy.
Endoscopy.
2003;
35
679-682
28
Heuss L T, Schnieper P, Drewe J. et al .
Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases.
Gastrointest Endosc.
2003;
57
664-671
29
Walker J A, McIntyre R D, Schleinitz P F. et al .
Nurse-administered propofol sedation without anesthesia specialists in 9152 endoscopic cases in an ambulatory surgery center.
Am J Gastroenterol.
2003;
98
1744-1750
31
Heuss L T, Schnieper P, Pflimlin E, Beglinger C.
Nurse-administered sedation with propofol under observation of the endoscopist: a prospective observation study with more than 5000 patients [abstract].
Gastrointest Endosc.
2003;
57
AB105
